當(dāng)前位置：首頁(yè) SCI期刊 SCIE期刊醫(yī)學(xué) 中科院3區(qū) JCRQ2 期刊介紹(非官網(wǎng))

Expert Review Of Gastroenterology & HepatologySCIE

國(guó)際簡(jiǎn)稱(chēng)：EXPERT REV GASTROENT 參考譯名：胃腸病學(xué)和肝病學(xué)專(zhuān)家評(píng)論

中科院分區(qū)
3區(qū)
CiteScore分區(qū)
Q1
JCR分區(qū)
Q2

基本信息：: ISSN：1747-4124; E-ISSN：1747-4132; 是否OA：未開(kāi)放; 是否預(yù)警：否; TOP期刊：否

出版信息：: 出版地區(qū)：ENGLAND; 出版商：Taylor and Francis Ltd.; 出版語(yǔ)言：English; 出版周期：8 issues/year; 出版年份：2007; 研究方向：GASTROENTEROLOGY & HEPATOLOGY

評(píng)價(jià)信息：: 影響因子：3.8; H-index：41; CiteScore指數(shù)：6.8; SJR指數(shù)：1.09; SNIP指數(shù)：0.975

發(fā)文數(shù)據(jù)：: Gold OA文章占比：10.34%; 研究類(lèi)文章占比：22.02%; 年發(fā)文量：109; 自引率：0.0256...; 開(kāi)源占比：0.071; 出版撤稿占比：0; 出版國(guó)人文章占比：0.14; OA被引用占比：0.0243...

投稿咨詢(xún) 加急見(jiàn)刊

英文簡(jiǎn)介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見(jiàn)問(wèn)題

英文簡(jiǎn)介Expert Review Of Gastroenterology & Hepatology期刊介紹

The enormous health and economic burden of gastrointestinal disease worldwide warrants a sharp focus on the etiology, epidemiology, prevention, diagnosis, treatment and development of new therapies. By the end of the last century we had seen enormous advances, both in technologies to visualize disease and in curative therapies in areas such as gastric ulcer, with the advent first of the H2-antagonists and then the proton pump inhibitors - clear examples of how advances in medicine can massively benefit the patient. Nevertheless, specialists face ongoing challenges from a wide array of diseases of diverse etiology.

期刊簡(jiǎn)介Expert Review Of Gastroenterology & Hepatology期刊介紹

《Expert Review Of Gastroenterology & Hepatology》自2007出版以來(lái)，是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個(gè)領(lǐng)域的原創(chuàng)研究提供一個(gè)展示平臺(tái)，以促進(jìn)醫(yī)學(xué)領(lǐng)域的的進(jìn)步。該刊鼓勵(lì)先進(jìn)的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見(jiàn)解，或?qū)彶槎嗄陙?lái)某個(gè)重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時(shí)報(bào)道醫(yī)學(xué)領(lǐng)域的最新進(jìn)展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點(diǎn)：

預(yù)計(jì)審稿時(shí)間：較慢,6-12周
醫(yī)學(xué)
GASTROENTEROLOGY & HEPATOLOGY
SCIE
中科院3區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）Expert Review Of Gastroenterology & Hepatology Cite Score數(shù)據(jù)

CiteScore：6.8
SJR：1.09
SNIP：0.975

學(xué)科類(lèi)別	分區(qū)	排名	百分位
大類(lèi)：Medicine 小類(lèi)：Gastroenterology	Q1	31 / 167	81%
大類(lèi)：Medicine 小類(lèi)：Hepatology	Q2	25 / 82	70%

CiteScore 是由Elsevier(愛(ài)思唯爾)推出的另一種評(píng)價(jià)期刊影響力的文獻(xiàn)計(jì)量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫(kù)中收集的引文為基礎(chǔ)，針對(duì)的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評(píng)價(jià)期刊影響力的方法，而不僅僅是通過(guò)影響因子(IF)這一單一指標(biāo)來(lái)評(píng)價(jià)。

歷年Cite Score趨勢(shì)圖

中科院SCI分區(qū)Expert Review Of Gastroenterology & Hepatology 中科院分區(qū)

中科院 2023年12月升級(jí)版 綜述期刊：是 Top期刊：否

大類(lèi)學(xué)科	分區(qū)	小類(lèi)學(xué)科	分區(qū)
醫(yī)學(xué)	3區(qū)	GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學(xué)	4區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運(yùn)用科學(xué)計(jì)量學(xué)方法對(duì)國(guó)際、國(guó)內(nèi)學(xué)術(shù)期刊依據(jù)影響力進(jìn)行等級(jí)劃分的期刊評(píng)價(jià)標(biāo)準(zhǔn)。它為我國(guó)科研、教育機(jī)構(gòu)的管理人員、科研工作者提供了一份評(píng)價(jià)國(guó)際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國(guó)各地高校、科研機(jī)構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個(gè)層次，類(lèi)似于“優(yōu)、良、及格”等。最開(kāi)始，這個(gè)分區(qū)只是為了方便圖書(shū)管理及圖書(shū)情報(bào)領(lǐng)域的研究和期刊評(píng)估。之后中科院分區(qū)逐步發(fā)展成為了一種評(píng)價(jià)學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢(shì)圖

JCR分區(qū)Expert Review Of Gastroenterology & Hepatology JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q2	37 / 143	74.5%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q2	65 / 143	54.9%

JCR分區(qū)的優(yōu)勢(shì)在于它可以幫助讀者對(duì)學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評(píng)估。不同學(xué)科的文章引用量可能存在較大的差異，此時(shí)單獨(dú)依靠影響因子(IF)評(píng)價(jià)期刊的質(zhì)量可能是存在一定問(wèn)題的。因此，JCR將期刊按照學(xué)科門(mén)類(lèi)和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢(shì)圖

發(fā)文數(shù)據(jù)

2023-2024 年國(guó)家/地區(qū)發(fā)文量統(tǒng)計(jì)

國(guó)家/地區(qū)數(shù)量
USA90
Italy80
CHINA MAINLAND76
England41
Australia19
Spain17
Egypt16
France16
Japan14
Brazil13

本刊中國(guó)學(xué)者近年發(fā)表論文

1、Early alpha-fetoprotein response predicts prognosis of immune checkpoint inhibitor and targeted therapy for hepatocellular carcinoma: a systematic review with meta-analysis
Author: Tian, Bao-Wen; Yan, Lun-Jie; Ding, Zi-Niu; Liu, Hui; Meng, Guang-Xiao; Xue, Jun-Shuai; Han, Cheng-Long; Dong, Zhao-Ru; Hong, Jian-Guo; Chen, Zhi-Qiang; Wang, Dong-Xu; Li, Tao

Journal: EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. 2023; Vol. 17, Issue 1, pp. 73-83. DOI: 10.1080/17474124.2022.2156859
2、The efficacy and safety of glucocorticoid for perioperative patients with hepatectomy: a systematic review and meta-analysis
Author: Liu, Lili; Zhang, Chengren; Lu, Tingting; Li, Xiong; Jiang, Zhiliang; Tian, Hongwei; Hao, Xiangyong; Yang, Kehu; Guo, Tiankang

Journal: EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. 2023; Vol. 17, Issue 1, pp. 59-71. DOI: 10.1080/17474124.2023.2162878
3、Research progress on short-term prognosis of acute-on-chronic liver failure
Author: Ma, Luyao; Liu, Siqi; Xing, Hao; Jin, Zhenjing

Journal: EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. 2023; Vol. 17, Issue 1, pp. 45-57. DOI: 10.1080/17474124.2023.2165063
4、The interaction of T2DM and BMI with NASH in recipients of liver transplants: an SRTR database analysis
Author: Xu, Fangshen; Zhang, Siyao; Ye, Danni; Chen, Zheng; Ding, Jiawei; Zhang, Tao; Ren, Shenli; Zhang, Yu; Zheng, Huilin; Zhou, Jie; Hu, Zhenhua

Journal: EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. 2023; Vol. 17, Issue 2, pp. 215-223. DOI: 10.1080/17474124.2023.2165489
5、The association of fatty liver and risk of hepatocellular carcinoma in HBV or HCV infected individuals: a systematic review and meta-analysis
Author: Han, Cheng-Long; Tian, Bao-Wen; Yang, Chun-Cheng; Yang, Ya-Fei; Ma, Yun-Long; Ding, Zi-Niu; Yan, Lun-Jie; Liu, Hui; Dong, Zhao-Ru; Chen, Zhi-Qiang; Hong, Jian-Guo; Wang, Dong-Xu; Li, Tao

Journal: EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. 2023; Vol. 17, Issue 2, pp. 189-198. DOI: 10.1080/17474124.2023.2166930
6、CT-based radiomics nomogram for differentiating gastric hepatoid adenocarcinoma from gastric adenocarcinoma: a multicentre study
Author: Wang, Jing; Kang, Bing; Sun, Cong; Du, Fengying; Lin, Jianxian; Ding, Fanghui; Dai, Zhengjun; Zhang, Yifei; Yang, Chenggang; Shang, Liang; Li, Leping; Hong, Qingqi; Huang, Changming; Wang, Guangbin

Journal: EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. 2023; Vol. 17, Issue 2, pp. 205-214. DOI: 10.1080/17474124.2023.2166490
7、New progress with calcium-binding protein S100A16 in digestive system disease
Author: Li, Binbin; Zhu, Wanqing; Shi, Di; Che, Huilin; Lyu, Qinglan; Jiang, Bimei

Journal: EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. 2023; Vol. 17, Issue 3, pp. 263-272. DOI: 10.1080/17474124.2023.2174968
8、Comparative efficacy of glucagon-like peptide 1 (GLP-1) receptor agonists, pioglitazone and vitamin E for liver histology among patients with nonalcoholic fatty liver disease: systematic review and pilot network meta-analysis of randomized controlled trials
Author: Gu, Yunpeng; Sun, Lei; He, Yining; Yang, Luping; Deng, Chaohua; Zhou, Run; Kong, Tingting; Zhang, Wei; Chen, Yutong; Li, Jie; Shi, Junping

Journal: EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. 2023; Vol. 17, Issue 3, pp. 273-282. DOI: 10.1080/17474124.2023.2172397